207 related articles for article (PubMed ID: 22155544)
21. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
22. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the anticancer activities of paclitaxel by Cremophor micelles.
Chiang JL; Yang YW
Int J Pharm; 2021 Jun; 603():120699. PubMed ID: 33992713
[TBL] [Abstract][Full Text] [Related]
24. Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model.
Ajorlou E; Khosroushahi AY; Yeganeh H
Pharm Res; 2016 Jun; 33(6):1426-39. PubMed ID: 26908046
[TBL] [Abstract][Full Text] [Related]
25. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.
Huo M; Zhang Y; Zhou J; Zou A; Yu D; Wu Y; Li J; Li H
Int J Pharm; 2010 Jul; 394(1-2):162-73. PubMed ID: 20457237
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations.
Zhang DY; Dmello C; Chen L; Arrieta VA; Gonzalez-Buendia E; Kane JR; Magnusson LP; Baran A; James CD; Horbinski C; Carpentier A; Desseaux C; Canney M; Muzzio M; Stupp R; Sonabend AM
Clin Cancer Res; 2020 Jan; 26(2):477-486. PubMed ID: 31831565
[TBL] [Abstract][Full Text] [Related]
28. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration.
Chen N; Brachmann C; Liu X; Pierce DW; Dey J; Kerwin WS; Li Y; Zhou S; Hou S; Carleton M; Klinghoffer RA; Palmisano M; Chopra R
Cancer Chemother Pharmacol; 2015 Oct; 76(4):699-712. PubMed ID: 26231955
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel formulation for peritoneal dissemination.
Emoto S; Yamaguchi H; Kishikawa J; Yamashita H; Ishigami H; Kitayama J
Cancer Sci; 2012 Jul; 103(7):1304-10. PubMed ID: 22429777
[TBL] [Abstract][Full Text] [Related]
30. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
31. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
32. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.
Adjei IM; Sharma B; Peetla C; Labhasetwar V
J Control Release; 2016 Jun; 232():83-92. PubMed ID: 27090164
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the efficacy and safety of a new formulation-lipid emulsion-based PTX injection: Pharmacokinetics, tissue distributions and anticancer effect on human gastric cancer cells in vitro.
Fei Y; Wang Y; Wu S; Shen F; Fan G
Biomed Chromatogr; 2021 Aug; 35(8):e5107. PubMed ID: 33651440
[TBL] [Abstract][Full Text] [Related]
35. Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.
Sparreboom A; Verweij J; van der Burg ME; Loos WJ; Brouwer E; Viganò L; Locatelli A; de Vos AI; Nooter K; Stoter G; Gianni L
Clin Cancer Res; 1998 Aug; 4(8):1937-42. PubMed ID: 9717822
[TBL] [Abstract][Full Text] [Related]
36. PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma.
Luo T; Loira-Pastoriza C; Patil HP; Ucakar B; Muccioli GG; Bosquillon C; Vanbever R
J Control Release; 2016 Oct; 239():62-71. PubMed ID: 27515664
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.
Vicari L; Musumeci T; Giannone I; Adamo L; Conticello C; De Maria R; Pignatello R; Puglisi G; Gulisano M
BMC Cancer; 2008 Jul; 8():212. PubMed ID: 18657273
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity.
Monteiro LOF; Fernandes RS; Castro L; Reis D; Cassali GD; Evangelista F; Loures C; Sabino AP; Cardoso V; Oliveira MC; Branco de Barros A; Leite EA
Mol Pharm; 2019 Aug; 16(8):3477-3488. PubMed ID: 31257891
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study.
Briasoulis E; Karavasilis V; Tzamakou E; Haidou C; Piperidou C; Pavlidis N
Anticancer Drugs; 2002 Jun; 13(5):481-9. PubMed ID: 12045459
[TBL] [Abstract][Full Text] [Related]
40. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q
J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
